Home » Newsletters » BioWorld Science

BioWorld Science

March 5, 1997

View Archived Issues

Astra year-end report January-December 1996

IDEC Pharmaceuticals reports 1996 fourth-quarter and year-end results

Magainin announces 1996 financial results

NABI reports 1996 financial results

WF-10 undergoes further clinical studies for AIDS

CoCensys initiates migraine trial

Matrix selects distribution partner for Italy

ChemTrak H. pylori test approved

Pfizer develops ACAT inhibitors

Akzo Nobel discloses MAb for HCV detection

Antidiabetic/hypolipidemic agents from Sumitomo Metal

Steroidal antitumor agents described by Taisho

Knoll reveals compounds with 5-HT1A receptor affinity

HLE inhibitors from P&U

ET antagonists from Warner-Lambert

Protein kinase inhibitors reported by Roche

Lp-PLA2 inhibitors disclosed by SKB

Selective stromelysin-1 inhibitor described by Merck & Co.

Orally active inhibitor of Ras farnesylation reported by Schering-Plough

GelTex receives U.S. patent for CholestaGel

GenPharm and Centocor to codevelop human antibodies

Novo Nordisk to develop compounds discovered by Indian research foundation

Clinical results for Murex/Innogenetics HIV-1 RT test

IDEC and Roche submit applications for IDEC-C2B8

Biogen signs distribution agreement with Genesis Pharma

Protein Design Labs grants license to Biogen for humanized antibodies

Medarex acquires Houston Biotechnology

SangStat receives European patent for Xenoject drugs

Caelyx available in additional countries

RAS inhibitors reduce mortality in a model of cerebral ischemia

Update on Sparta's asulacrine

Oral mucositis treatment proceeds to phase II

Novel post-Amadori inhibitors identified

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...